Advertisement
Screener

HEARTBEAM, INC. (BEAT) Graph

BEAT Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Research and development $2.33M; Selling, general and administrative (m); Operating expenses $5.09M; Income tax $0.00.
  • 2026-03-31: Research and development $2.37M; Selling, general and administrative (m); Operating expenses $4.72M; Income tax $0.00.
  • 2025-12-31: Research and development $3.35M*; Selling, general and administrative (m); Operating expenses $5.31M*; Income tax $0.00*.
  • 2025-09-30: Research and development $3.28M; Selling, general and administrative (m); Operating expenses $5.29M; Income tax $0.00.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$2.33M(m)$5.09M$0.00-$5.04M
2026-03-31$2.37M(m)$4.72M$0.00-$4.70M
2025-12-31$3.35M*(m)$5.31M*$0.00*-$5.30M*
2025-09-30$3.28M(m)$5.29M$0.00-$5.25M
2025-06-30$3.33M(m)$5.04M$0.00-$4.97M
2025-03-31$3.49M(m)$5.50M$0.00-$5.48M
2024-09-30$2.89M(m)$5.07M$0.00-$4.98M
2024-06-30$2.84M(m)$5.09M$0.00-$4.96M
2024-03-31$2.43M(m)$4.78M$0.00-$4.61M
2023-09-30$1.62M(m)$3.74M$0.00-$3.47M
2023-06-30$1.48M(m)$3.31M$0.00-$3.15M
2023-03-31$1.68M(m)$4.16M$0.00-$4.14M
2022-09-30$1.56M(m)$3.61M$0.00-$3.58M
2022-06-30$1.74M(m)$3.54M$0.00-$3.52M
2022-03-31$734.00K(m)$2.15M$0.00-$2.15M
2021-09-30$105.00K$341.00K$446.00K$0.00-$1.19M
2021-06-30$25.00K(m)$337.00K$0.00-$945.00K
2021-03-31$29.00K(m)$163.00K$0.00-$210.00K
2020-09-30$57.00K$215.00K$272.00K$0.00-$335.00K

Revenue and expense 6 month

Period endResearch and developmentOperating expensesIncome taxNet income
2026-06-30$4.70M$9.81M$0.00-$9.74M
2025-06-30$6.82M$10.54M$0.00-$10.46M
2024-06-30$5.27M$9.87M$0.00-$9.56M
2023-06-30$3.17M$7.47M$0.00-$7.29M
2022-06-30$2.48M$5.68M$0.00-$5.67M
2021-06-30$54.00K$500.00K$0.00-$1.16M

Revenue and expense 9 month

Period endResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$10.10M(m)$15.83M$0.00-$15.71M
2024-09-30$8.16M(m)$14.94M$0.00-$14.54M
2023-09-30$4.79M(m)$11.21M$0.00-$10.76M
2022-09-30$4.04M(m)$9.29M$0.00-$9.25M
2021-09-30$159.00K$785.00K$944.00K$0.00-$2.34M
2020-09-30$86.00K$441.00K$527.00K$0.00-$737.00K

Revenue and expense 12 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-12-31$13.45M$21.14M$0.00-$21.02M
2024-12-31$11.05M$19.89M$0.00-$19.45M
2023-12-31$6.80M$15.31M$0.00-$14.64M
2022-12-31$5.68M$13.03M$0.00-$12.96M
2021-12-31$255.00K$2.29M$0.00-$4.43M
2020-12-31$133.00K$788.00K$0.00-$1.07M

Similar stocks

Stock NameCountryMarket CapPE Ratio
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
ACCURAY INC (ARAY)United States$0.027B-0.63
Glucotrack, Inc. (GCTK)United States$0.027B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
PAVmed Inc. (PAVM)United States$0.031B-3.00